X
19
Biogen, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
One of their notable products is DACLIZUMAB, with a corresponding application number 761029 and regulatory information .
proudly manufactured in the
Biogen's ZINBRYTA INJECTABLE;INJECTION, medication with 150MG/ML of DACLIZUMAB.